Blake B. Gorman, D.O.
Clinical Assistant Professor, Wichita - Anesthesiology
Associate Program Director, Associate Program Director, University of Kansas School of Medicine- Wichita, Wichita - Anesthesiology
Professional Background
Dr. Blake Gorman is a board-certified anesthesiologist with Anesthesia Consulting Services at Ascension Via Christi Saint Francis and Saint Teresa Hospitals. He is also board certified in critical care and neurocritical care where he serves as a neurointensivist in the neurocritical care ICU at Ascension Via Christi St. Francis Hospital. Dr. Gorman has been the KU SOM-Wichita anesthesiology residency's associate program director since the beginning of 2023. Through this appointment he serves on multiple committees and is very active in resident education and within the quality improvement department.
Medical School: Oklahoma State University Center for Health Sciences
Residency: University of Kansas School of Medicine - Wichita
Fellowship: Critical Care Medicine at University of Nebraska Medical Center
Education and Training
- BS, Cellular Biology, Northeastern State University, Tahlequah, OK
- DO, Medicine, Oklahoma State University- Center for Health Sciences, Tulsa, OK
- Residency, Anesthesiology, University of Kansas- Wichita, Wichita, KS
- Clinical Fellowship, Critical Care Medicine, University of Nebraska Medical Center, Omaha, NE
Professional Affiliations
- Society of Academic Associations of Anesthesiology and Perioperative Medicine, Society of Academic Associations of Anesthesiology and Perioperative Medicine, Member, 2023 - Present
- Neurocritical Care Society, Neurocritical Care Society, Member, 2022 - Present
- Society of Critical Care Medicine, Society of Critical Care Medicine, Member, 2018 - Present
- American Society of Anesthesiology, American Society of Anesthesiology, Political Action Committee, KUSOM-W Program Representative, 2016 - 2017
- American Board of Anesthesiology, American Board of Anesthesiology, Member, 2014 - Present
- American Society of Anesthesiology, American Society of Anesthesiology, Member, 2014 - Present
Current Research and Grants
- Lidocaine Infusion as a Treatment Modality for Headache Following Non-Traumatic Subarachnoid Hemorrhage: A Prospective, Single-Center, Observational Cohort Study, none
- Librexia-STROKE: A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention after an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack, Janssen Research and Development
- Treatment of Acute Ischemic Stroke (ReMEDy2 Trial), DiaMedica Therapeutics Inc.